IMMUNO-CHEMOTHERAPY CONTAINING RITUXIMAB IS ASSOCIATED WITH IMPROVED SURVIVAL IN PRIMARY CNS B CELL LYMPHOMA
Conference Paper
-
- Overview
-
- Additional Document Info
-
- View All
-
Overview
publication date
has subject area
published in
Additional Document Info
Publisher
-
FERRATA STORTI FOUNDATION
start page
end page
volume